Summary

Persistence Market Research has recently released a detailed report on the global Urolithiasis Management Devices Market, offering a thorough analysis of key market factors such as drivers, trends, opportunities, and challenges. The report provides valuable insights into the market structure.

Key Highlights:

• Urolithiasis Management Devices Market Size (2024E): US$1.7 Bn
• Projected Market Value (2030F): US$2.2 Bn
• Global Market Growth Rate (CAGR 2024 to 2030): 4.4%

Scope of the Urolithiasis Management Devices Market Report:

The Urolithiasis Management Devices Market covers a range of devices used to treat urolithiasis (kidney stones), including lithotripsy systems, ureteroscopes, nephroscopes, and stone retrieval tools. These devices are integral to minimally invasive and non-invasive kidney stone treatments, catering to hospitals, ambulatory surgical centers, and specialty clinics. Market growth is driven by a rising prevalence of urolithiasis, technological advancements, and increasing awareness of early diagnosis and treatment.

Market Growth Drivers:

The global Urolithiasis Management Devices Market is being propelled by several key factors. The growing incidence of kidney stones, which is influenced by shifts in diet, lifestyle, and aging populations, is a major driver. Technological innovations in lithotripsy and endoscopy devices have enabled more effective, less invasive treatments, further boosting market growth. Increased awareness about the symptoms and treatment options for urolithiasis encourages earlier diagnosis and treatment, fueling demand.

Market Challenges:

Despite strong growth prospects, the Urolithiasis Management Devices Market faces some challenges. High costs associated with advanced treatment devices and procedures present a significant barrier. Additionally, potential complications from treatment, such as bleeding or infections, may hinder growth. Some patients may opt for more traditional, cost-effective treatments, slowing the adoption of advanced devices. Furthermore, limited access to high-quality healthcare infrastructure in certain regions poses challenges for market expansion.

Market Opportunities:

The market offers significant opportunities, particularly with the growing demand for minimally invasive treatments and advancements in urolithiasis management technology. Innovations like advanced laser lithotripsy and robotic-assisted procedures are expected to meet the increasing demand for precise, efficient treatments. Developing healthcare infrastructure in emerging regions and rising disposable incomes open new avenues for growth. Additionally, ongoing research and development efforts aimed at improving device safety and efficacy are expected to unlock further opportunities.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the Urolithiasis Management Devices Market globally?
• Which types of devices are leading the adoption in various treatment settings?
• How are technological advancements influencing the competitive landscape of the Urolithiasis Management Devices Market?
• Who are the key players in the Urolithiasis Management Devices Market, and what strategies are they employing to stay competitive?
• What are the emerging trends and future prospects in the global Urolithiasis Management Devices Market?

Competitive Landscape and Business Strategy:

Top players in the Urolithiasis Management Devices Market, including Olympus Corporation, Boston Scientific Corporation, and KARL STORZ, are focused on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies are investing heavily in research and development to create advanced solutions for urolithiasis management and explore new product formats. Collaborations with healthcare providers and distributors are key to expanding market access and promoting the adoption of new devices. Additionally, companies emphasize providing high-quality devices, medical professional training, and robust marketing strategies to drive growth and enhance brand loyalty in the evolving Urolithiasis Management Devices Market.

Key Companies Profiled:

• Allengers
• Boston Scientific
• BD
• Cook Medical
• ConMed
• DirexGroup
• Dornier MedTech
• KARL STORZ
• Potent Optotronic
• HealthTronics
• Lumenis
• Olympus
• Richard Wolf
• Siemens Healthcare

Urolithiasis Management Devices Market Industry Segmentation

By Treatment Type:

• Extracorporeal Shock Wave Lithotripsy (ESWL)
• Percutaneous Nephrolithotomy
• Intracorporeal Lithotripsy
• Others

By Product Type:

• Lithotripters
• Ureteroscopes

By End User:

• Hospitals and Clinics
• Ambulatory Surgical Centers (ASCs)

By Region:

• North America
• Europe
• East Asia
• South Asia & Oceania
• Latin America
• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Urolithiasis Management Devices Market Snapshot, 2024-2030
1.2. Market Opportunity Assessment, 2024-2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Treatment Type Lifecycle Analysis
2.4. Urolithiasis Management Devices Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Applications
2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape
3. Global Urolithiasis Management Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2030)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Bn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2019-2023
3.2.2. Current Market Size Forecast, 2019-2023
3.3. Global Urolithiasis Management Devices Market Outlook: Treatment Type
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Treatment Type, 2019-2023
3.3.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Treatment Type, 2024-2030
3.3.3.1. Extracorporeal Shock Wave Lithotripsy (ESWL)
3.3.3.2. Percutaneous Nephrolithotomy
3.3.3.3. Intracorporeal Lithotripsy
3.3.3.4. Others
3.4. Market Attractiveness Analysis: Treatment Type
3.5. Global Urolithiasis Management Devices Market Outlook: Product Type
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Product Type, 2019-2023
3.5.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Product Type, 2024-2030
3.5.3.1. Lithotripters
3.5.3.2. Ureteroscopes
3.6. Market Attractiveness Analysis: Product Type
3.7. Global Urolithiasis Management Devices Market Outlook: End User
3.7.1. Introduction / Key Findings
3.7.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By End User, 2019-2023
3.7.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By End User, 2024-2030
3.7.3.1. Hospitals and Clinics
3.7.3.2. Ambulatory Surgical Centers (ASCs)
3.8. Market Attractiveness Analysis: End User
4. Global Urolithiasis Management Devices Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Region, 2019-2023
4.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Region, 2024-2030
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia and Oceania
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America Urolithiasis Management Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2030)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019-2023
5.3.1. By Country
5.3.2. By Treatment Type
5.3.3. By Product Type
5.3.4. By End User
5.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2024-2030
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Treatment Type, 2024-2030
5.5.1. Extracorporeal Shock Wave Lithotripsy (ESWL)
5.5.2. Percutaneous Nephrolithotomy
5.5.3. Intracorporeal Lithotripsy
5.5.4. Others
5.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Product Type, 2024-2030
5.6.1. Mechanical
5.6.2. Ureteroscopes
5.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By End User, 2024-2030
5.7.1. Hospitals and Clinics
5.7.2. Ambulatory Surgical Centers (ASCs)
5.8. Market Attractiveness Analysis
6. Europe Urolithiasis Management Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019-2023
6.3.1. By Country
6.3.2. By Treatment Type
6.3.3. By Product Type
6.3.4. By End User
6.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2024-2030
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Turkey
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Treatment Type, 2024-2030
6.5.1. Extracorporeal Shock Wave Lithotripsy (ESWL)
6.5.2. Percutaneous Nephrolithotomy
6.5.3. Intracorporeal Lithotripsy
6.5.4. Others
6.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Product Type, 2024-2030
6.6.1. Mechanical
6.6.2. Ureteroscopes
6.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By End User, 2024-2030
6.7.1. Hospitals and Clinics
6.7.2. Ambulatory Surgical Centers (ASCs)
6.8. Market Attractiveness Analysis
7. East Asia Urolithiasis Management Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019-2023
7.3.1. By Country
7.3.2. By Treatment Type
7.3.3. By Product Type
7.3.4. By End User
7.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2024-2030
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Treatment Type, 2024-2030
7.5.1. Extracorporeal Shock Wave Lithotripsy (ESWL)
7.5.2. Percutaneous Nephrolithotomy
7.5.3. Intracorporeal Lithotripsy
7.5.4. Others
7.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Product Type, 2024-2030
7.6.1. Mechanical
7.6.2. Ureteroscopes
7.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By End User, 2024-2030
7.7.1. Hospitals and Clinics
7.7.2. Ambulatory Surgical Centers (ASCs)
7.8. Market Attractiveness Analysis
8. South Asia & Oceania Urolithiasis Management Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019-2023
8.3.1. By Country
8.3.2. By Treatment Type
8.3.3. By Product Type
8.3.4. By End User
8.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2024-2030
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Treatment Type, 2024-2030
8.5.1. Extracorporeal Shock Wave Lithotripsy (ESWL)
8.5.2. Percutaneous Nephrolithotomy
8.5.3. Intracorporeal Lithotripsy
8.5.4. Others
8.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Product Type, 2024-2030
8.6.1. Mechanical
8.6.2. Ureteroscopes
8.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By End User, 2024-2030
8.7.1. Hospitals and Clinics
8.7.2. Ambulatory Surgical Centers (ASCs)
8.8. Market Attractiveness Analysis
9. Latin America Urolithiasis Management Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019-2023
9.3.1. By Country
9.3.2. By Treatment Type
9.3.3. By Product Type
9.3.4. By End User
9.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2024-2030
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Treatment Type, 2024-2030
9.5.1. Extracorporeal Shock Wave Lithotripsy (ESWL)
9.5.2. Percutaneous Nephrolithotomy
9.5.3. Intracorporeal Lithotripsy
9.5.4. Others
9.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Product Type, 2024-2030
9.6.1. Mechanical
9.6.2. Ureteroscopes
9.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By End User, 2024-2030
9.7.1. Hospitals and Clinics
9.7.2. Ambulatory Surgical Centers (ASCs)
9.8. Market Attractiveness Analysis
10. Middle East & Africa Urolithiasis Management Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019-2023
10.3.1. By Country
10.3.2. By Treatment Type
10.3.3. By Product Type
10.3.4. By End User
10.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2024-2030
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Treatment Type, 2024-2030
10.5.1. Extracorporeal Shock Wave Lithotripsy (ESWL)
10.5.2. Percutaneous Nephrolithotomy
10.5.3. Intracorporeal Lithotripsy
10.5.4. Others
10.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Product Type, 2024-2030
10.6.1. Mechanical
10.6.2. Ureteroscopes
10.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By End User, 2024-2030
10.7.1. Hospitals and Clinics
10.7.2. Ambulatory Surgical Centers (ASCs)
10.8. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2024
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Dashboard
11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. Allengers
11.3.1.1. Overview
11.3.1.2. Segments and Product
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. Boston Scientific
11.3.2.1. Overview
11.3.2.2. Segments and Product
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. BD
11.3.3.1. Overview
11.3.3.2. Segments and Product
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. Cook Medical
11.3.4.1. Overview
11.3.4.2. Segments and Product
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. ConMed
11.3.5.1. Overview
11.3.5.2. Segments and Product
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
11.3.6. DirexGroup
11.3.6.1. Overview
11.3.6.2. Segments and Product
11.3.6.3. Key Financials
11.3.6.4. Market Developments
11.3.6.5. Market Strategy
11.3.7. Dornier MedTech
11.3.7.1. Overview
11.3.7.2. Segments and Product
11.3.7.3. Key Financials
11.3.7.4. Market Developments
11.3.7.5. Market Strategy
11.3.8. KARL STORZ
11.3.8.1. Overview
11.3.8.2. Segments and Product
11.3.8.3. Key Financials
11.3.8.4. Market Developments
11.3.8.5. Market Strategy
11.3.9. Potent Optotronic
11.3.9.1. Overview
11.3.9.2. Segments and Product
11.3.9.3. Key Financials
11.3.9.4. Market Developments
11.3.9.5. Market Strategy
11.3.10. HealthTronics
11.3.10.1. Overview
11.3.10.2. Segments and Product
11.3.10.3. Key Financials
11.3.10.4. Market Developments
11.3.10.5. Market Strategy
11.3.11. Lumenis
11.3.11.1. Overview
11.3.11.2. Segments and Product
11.3.11.3. Key Financials
11.3.11.4. Market Developments
11.3.11.5. Market Strategy
11.3.12. Olympus
11.3.12.1. Overview
11.3.12.2. Segments and Product
11.3.12.3. Key Financials
11.3.12.4. Market Developments
11.3.12.5. Market Strategy
11.3.13. Richard Wolf
11.3.13.1. Overview
11.3.13.2. Segments and Product
11.3.13.3. Key Financials
11.3.13.4. Market Developments
11.3.13.5. Market Strategy
11.3.14. Siemens Healthcare
11.3.14.1. Overview
11.3.14.2. Segments and Product
11.3.14.3. Key Financials
11.3.14.4. Market Developments
11.3.14.5. Market Strategy
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations